Imago Biosciences Inc. seemed to materialize from thin air, on Halloween at that, with a $26.5 million series A financing led by Clarus Ventures LLC, with participation from an impressive syndicate that included Frazier Healthcare, Amgen Ventures and Merck Research Labs Venture Fund.